黄芪甲苷调控内皮祖细胞外泌体miR-126-5p对高糖受损内皮细胞生物学功能及血管生长因子的影响OA
The Effect of Astragaloside Ⅳ-Mediated Endothelial Progenitor Cell Exosomal miR-126-5p on the Biological Functions and Secretion of Vascular Growth Factors in High Glucose-Damaged Endothelial Cells
目的:探讨黄芪甲苷(AS-Ⅳ)调控内皮祖细胞(EPCs)外泌体miR-126-5p对高糖受损人脐静脉内皮细胞(HUVECs)生物学功能及血管生长因子的影响.方法:分离培养并鉴定人EPCs与HUVECs.将鉴定成功的EPCs分别用PBS、AS-Ⅳ处理,培养24 h收集EPCexos,用透射电镜观察其形态.用miR-126-5p inhibitor、inhibitor NC转染EPCs,再给予AS-Ⅳ处理并提取外泌体,实时荧光定量PCR(RT-qPCR)检测外泌体中miR-126-5p水平.将鉴定成功的HUVECs建立高糖损伤模型后分为高糖(HG)组、HG+EPCexos组、HG+AS-Ⅳ-EPCexos组、HG+miR-126-5p inhibitor+AS-Ⅳ-EPCexos组、HG+inhibitor NC+AS-Ⅳ-EPCexos组,同时设置正常组,共6组.培养48 h后,CCK-8法、Transwell实验、Matrigel成管实验及流式细胞术检测细胞增殖、迁移、成管及凋亡情况,蛋白质印迹法(Western blotting)检测血管内皮生长因子a(VEGFa)、血管内皮生长因子b(VEGFb)、血管内皮生长因子c(VEGFc)、成纤维细胞生长因子(FGF)、血管生成素-1(Ang-1)蛋白表达,RT-qPCR检测VEGFa mRNA、VEGFb mRNA、VEGFc mRNA、FGF mRNA、Ang-1 mRNA表达.结果:外泌体呈圆形或椭圆形微囊泡结构.HG+AS-Ⅳ-EPCexos组外泌体中 miR-126-5p相对表达量高于HG+EPCexos组(P<0.05);HG+miR-126-5p inhibitor+AS-Ⅳ-EPCexos组外泌体中miR-126-5p相对表达量低于HG+AS-Ⅳ-EPCexos组(P<0.05).与正常组比较,HG组HUVECs相对活力、迁移、成管能力均降低,凋亡率升高,血管生长因子表达下调(P<0.05);与HG组比较,HG+AS-Ⅳ-EPCexos组HUVECs相对活力、迁移、成管能力均升高,凋亡率降低,血管生长因子表达上调(P<0.05);与HG+AS-Ⅳ-EPCexos 组比较,HG+miR-126-5p inhibitor+AS-Ⅳ-EPCexos组HUVECs相对活力、迁移、成管能力均降低,凋亡率升高,血管生长因子表达下调(P<0.05).结论:AS-Ⅳ可上调EPCs来源外泌体中miR-126-5p的表达,改善高糖受损HUVECs血管新生功能.
Objective:To investigate the effects of astragaloside Ⅳ(AS-Ⅳ)-regulated miR-126-5p in exosomes derived from endothelial progenitor cells(EPCs)on the biological functions and vascular growth factors of high-glucose-damaged human umbilical vein endothelial cells(HUVECs).Methods:Human EPCs and HUVECs were isolated,cultured and characterised.Characterised EPCs were treated with PBS or AS-Ⅳ,respectively,and cultured for 24 hours before collecting EPC exosomes.Their morphology was observed using transmission electron microscopy.EPCs were transfected with a miR-126-5p inhibitor or a inhibitor-NC,followed by treatment with AS-Ⅳ and exosome extraction.The levels of miR-126-5p in the exosomes were detected using real-time fluorogenic quantitative PCR(RT-qPCR).Following the establishment of a high-glucose injury model in successfully identified HUVECs,the cells were divided into high-glucose(HG)group,HG+EPCexos group,HG+AS-Ⅳ-EPCexos group,HG+miR-126-5p inhibitor+AS-Ⅳ-EPCexos group,and HG+inhibitor NC+AS-Ⅳ-EPCexos group,with a control group also included,making a total of six groups.After 48 hours of culture,cell proliferation,migration,tube formation and apoptosis were assessed using the CCK-8 assay,Transwell assay,Matrigel tube formation assay and flow cytometry,respectively.Western blotting was used to detect the protein expression of vascular endothelial growth factor A(VEGF-α),vascular endothelial growth factor B(VEGF-β),vascular endothelial growth factor C(VEGFc),fibroblast growth factor(FGF)and angiopoietin-(Ang-1).RT-qPCR was used to detect the expression of VEGFa mRNA,VEGFb mRNA,VEGFc mRNA,FGF mRNA and Ang-1 mRNA.Results:The exosomes exhibited a round or oval microvesicular structure.The HG+AS-Ⅳ-EPCexos group showed higher miR-126-5p expression than that HG+EPCexos group(P<0.05).The HG+miR-126-5p inhibitor+AS-Ⅳ-EPCexos group showed lower miR-126-5p expression than HG+AS-Ⅳ-EPCexos group(P<0.05).Compared with the control group,the HG group exhibited reduced relative viability,migration and tubule formation capacity in HUVECs,along with increased apoptosis rates and down-regulated expression of vascular growth factors(P<0.05).Compared with the HG group,the HG+AS-Ⅳ-EPCexos group exhibited increased relative viability,migration and tubule formation capacity in HUVECs,along with reduced apoptosis rates and up-regulated expression of vascular growth factors(P<0.05).Compared with the HG+AS-Ⅳ-EPCexos group,the HG+miR-126-5p inhibitor+AS-Ⅳ-EPCexos group exhibited reduced relative viability,migration and tube formation capacity in HUVECs,increased apoptosis rates,and down-regulated expression of vascular growth factors(P<0.05).Conclusion:AS-Ⅳ can upregulate the expression of miR-126-5p in EPC-derived exosomes,thereby improving the angiogenic function of HUVECs damaged by high glucose.
胡清睿;张熙;曾楚若;郭东卫;邹晓玲;蒋阿堃;林芸冰;王小风;李雨桐;熊武
湖南中医药大学,湖南 长沙 410208湖南中医药大学,湖南 长沙 410208湖南省第二人民医院/湖南省脑科医院,湖南 长沙 410007湖南省第二人民医院/湖南省脑科医院,湖南 长沙 410007湖南中医药大学第一附属医院,湖南 长沙 410007湖南中医药大学中医学院,湖南 长沙 410208湖南中医药大学,湖南 长沙 410208湖南中医药大学,湖南 长沙 410208湖南中医药大学,湖南 长沙 410208湖南中医药大学第一附属医院,湖南 长沙 410007
医药卫生
黄芪甲苷内皮祖细胞外泌体miR-126-5p内皮细胞糖尿病血管病变高糖环境
astragaloside Ⅳendothelial progenitor cellsexosomesmiR-126-5pendothelial cellsdiabetic angiopathyhigh glucose condition
《中医药导报》 2026 (7)
9-16,8
湖南省自然科学基金高校联合基金重点项目(2025JJ90013)湖南中医药大学校院联合基金重点项目(2024XYLH199)长沙市自然科学基金项目(kq2502250)
评论